The sneaky virus poses serious health threats if it goes on to become a chronic disease. Clinical trial results suggest a new ...

Drug candidate bepirovirsen delivered a functional cure rate for 19% of patients in what the company sees as a breakthrough ...

New research implies that a first-of-its-kind drug for hepatitis B could allow some patients to stop treatment without ...

A first-of-its-kind drug for hepatitis B is letting some patients stop treatment without showing signs of the dangerous liver ...

A new drug has cured 20% of patients with a chronic, cancer-causing disease — which was previously incurable. A viral ...

Most people recover from the infection, but it poses great risks for those who don’t. A new drug may cure 1 in 5 of these ...

The findings supporting bepiroversen were deemed a “historic moment” by physicians and validate a drug that has “clear ...

GSK is pulling back the curtain on the phase 3 success of its chronic hepatitis B drug bepirovirsen, revealing that nearly ...

The antisense oligonucleotide was even more effective in patients with relatively low viral activity. More than one-quarter of these individuals had undetectable levels of the virus in the blood for ...

Researchers may have found a cure for Hepatits B, Eli Lilly bets big on vaccines and how to keep summer anxiety in check. Here are today's health headlines. (AP) ...

Two replicate phase 3 randomized controlled trials involving patients with chronic hepatitis B virus (HBV) infection demonstrate a functional cure after the discontinuation of conventional long-term ...

BARCELONA--GSK said a drug candidate for hepatitis B delivered a functional cure for nearly one fifth of patients in two late-stage clinical trials, in what the company sees as a breakthrough in the ...